Spectral Operating Margin from 2010 to 2026

EDT Stock  CAD 1.35  0.03  2.27%   
Spectral Med Operating Profit Margin yearly trend continues to be very stable with very little volatility. Operating Profit Margin is likely to drop to -4.96.
Check Spectral Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectral Med's main balance sheet or income statement drivers, such as Depreciation And Amortization of 214.6 K, Interest Expense of 3 M or Selling General Administrative of 7.3 M, as well as many indicators such as Price To Sales Ratio of 46.4, Dividend Yield of 0.36 or Days Sales Outstanding of 97.91. Spectral financial statements analysis is a perfect complement when working with Spectral Med Valuation or Volatility modules.
  
This module can also supplement various Spectral Med Technical models . Check out the analysis of Spectral Med Correlation against competitors.
Evaluating Spectral Med's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Spectral Med's fundamental strength.

Latest Spectral Med's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Spectral Med over the last few years. It is Spectral Med's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Spectral Med's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (4.13) %10 Years Trend
Pretty Stable
   Operating Profit Margin   
       Timeline  

Spectral Operating Margin Regression Statistics

Arithmetic Mean(4.90)
Coefficient Of Variation(113.16)
Mean Deviation2.75
Median(3.43)
Standard Deviation5.55
Sample Variance30.80
Range24.894
R-Value0.25
Mean Square Error30.72
R-Squared0.06
Significance0.32
Slope0.28
Total Sum of Squares492.81

Spectral Operating Margin History

2026 -4.96
2025 -4.72
2024 -5.25
2023 -7.15
2022 -5.07
2021 -3.34

About Spectral Med Financial Statements

Spectral Med investors utilize fundamental indicators, such as Operating Margin, to predict how Spectral Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 18 people.

Pair Trading with Spectral Med

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.

Moving against Spectral Stock

  0.55RVX Resverlogix CorpPairCorr
  0.49HSTR Heliostar MetalsPairCorr
  0.31ABBV AbbVie CDRPairCorr
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Spectral Stock

Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.